Clinical Trials Arena April 10, 2025
By focusing on the subject variables, the company claims to offer clinically grounded insights to sponsors.
Contract research organisation (CRO) Worldwide Clinical Trials (Worldwide) has introduced a new AI-driven tool for improving optimisation of studies.
This service aims to “segment” subject populations, detecting the potential ones exhibiting positive study outcomes, which results in significant reductions in trial subject numbers, timelines, and expenses for trial sponsors.
The tool leverages AI algorithms that are NetraMark-powered to process complex data sets such as genomics, clinical scales, and transcriptomics.
This analysis is crucial for detecting factors that can “optimise” endpoint results.
By focusing on the subject variables, the company offers sponsors transparent, rapid, clinically grounded insights.
These insights are instrumental in refining the design...
Today's Sponsors
Today's Sponsor